Beroni Group Announced the Latest Clinical Study of its SARS- CoV-2 Antigen Test Kit (Colloidal Gold Method)

  • Post author:
  • Post category:2021
  • Post comments:0 Comments

NEW YORK and SYDNEY, Australia, Aug. 31, 2021 -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, announced the latest clinical study of its SARS-CoV-2 Antigen Test…

Continue ReadingBeroni Group Announced the Latest Clinical Study of its SARS- CoV-2 Antigen Test Kit (Colloidal Gold Method)

Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment

  • Post author:
  • Post category:2021
  • Post comments:0 Comments

NEW YORK and SYDNEY,  Australia,  May  28,  2021 -  Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announced that it has signed a Memorandum of…

Continue ReadingBeroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment
Read more about the article Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit
Beroni ’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method)

Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit

  • Post author:
  • Post category:2021
  • Post comments:0 Comments

NEW YORK and SYDNEY, April 27, 2021, Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announced that it has received the notification that its SARS-CoV-2 Antigen Test…

Continue ReadingBeroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit